Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis

NCT06224036 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Drug-resistant Tuberculosis

Interventions

DRUG: JDB0131
DRUG: Delamanid
DRUG: Ethylpyrazine rifampicide (II)

Sponsor

Beijing Chest Hospital

Collaborators

[object Object]
[object Object]